Key Considerations for the Pre-Clinical Development of Therapeutic Innovations 

This webinar will provide a high-level look at the critical milestones and timelines for translating your therapeutic innovation to clinical reality, paying special attention to the unique impact clinical context and regulatory considerations have on your development pathway. Hear from therapeutic innovator Mukesh Nyati, Ph.D., as he discusses the preclinical development of a novel small molecule that selectively inhibits dimerization of active EGFR as a therapy for TKI resistant lung cancer.

To view Dr. Nyati’s portion of the presentation, please download the handouts below.

Join Fast Forward Medical Innovation for a series of webinars intended to educate and connect life science researchers and academic innovators interested in the commercialization of academic research.  The series outlines the significance and critical milestones of developing novel therapeutics, medical devices, diagnostics, and digital health innovations, as well as essential collaborations with industry partners to translate a research-based idea into a product of impact. 

September 8, 2020